COVID-19 Virulence in Aged Patients Might Be Impacted by the Host Cellular MicroRNAs Abundance/Profile
Sadanand Fulzele1,2, Bikash Sahay3, Ibrahim Yusufu1
11Department of Medicine, Augusta University, Augusta, GA, USA.
Insights
This study identified human microRNAs (miRNAs) that target the SARS-CoV-2 genome, finding that some crucial antiviral miRNAs decrease with age. This reduction may explain increased COVID-19 severity in older adults.
Area of Science:
- Virology
- Genomics
- Computational Biology
Background:
- Coronavirus disease 2019 (COVID-19) is a global pandemic with higher mortality in the elderly.
- Effective treatments are lacking, necessitating innovative therapeutic strategies.
- Host cellular microRNAs (miRNAs) can target viral genomes to exert antiviral effects.
Purpose of the Study:
- To perform an in silico analysis of human miRNAs targeting SARS and COVID-19 genomes.
- To correlate miRNA targeting with aging and underlying health conditions.
- To identify potential therapeutic targets for COVID-19.
Main Methods:
- In silico analysis of human miRNAs targeting SARS and COVID-19 genomes.
- Comparative analysis of miRNA targets across different viral isolates.
- Gene Ontology (GO) and KEGG pathway analysis.
Main Results:
- Identified 848 common miRNAs targeting SARS and 873 targeting COVID-19.
- Found 315 miRNAs unique to COVID-19 and 290 unique to SARS.
- GO and KEGG analysis revealed COVID-19 targeting miRNAs are involved in age-related signaling pathways, which are impaired by decreased miRNA abundance in aging individuals.
Conclusions:
- Human miRNAs play a role in targeting the SARS-CoV-2 genome.
- Reduced abundance of specific miRNAs with aging may contribute to increased COVID-19 severity and mortality.
- Further in vitro and in vivo studies are required to validate these findings and explore therapeutic potential.
Abstract:
The World health organization (WHO) declared Coronavirus disease 2019 (COVID-19) a global pandemic and a severe public health crisis. Drastic measures to combat COVID-19 are warranted due to its contagiousness and higher mortality rates, specifically in the aged patient population. At the current stage, due to the lack of effective treatment strategies for COVID-19 innovative approaches need to be considered. It is well known that host cellular miRNAs can directly target both viral 3'UTR and coding region of the viral genome to induce the antiviral effect. In this study, we did in silico analysis of human miRNAs targeting SARS (4 isolates) and COVID-19 (29 recent isolates from different regions) genome and correlated our findings with aging and underlying conditions. We found 848 common miRNAs targeting the SARS genome and 873 common microRNAs targeting the COVID-19 genome. Out of a total of 848 miRNAs from SARS, only 558 commonly present in all COVID-19 isolates. Interestingly, 315 miRNAs are unique for COVID-19 isolates and 290 miRNAs unique to SARS. We also noted that out of 29 COVID-19 isolates, 19 isolates have identical miRNA targets. The COVID-19 isolates, Netherland (EPI_ISL_422601), Australia (EPI_ISL_413214), and Wuhan (EPI_ISL_403931) showed six, four, and four unique miRNAs targets, respectively. Furthermore, GO, and KEGG pathway analysis showed that COVID-19 targeting human miRNAs involved in various age-related signaling and diseases. Recent studies also suggested that some of the human miRNAs targeting COVID-19 decreased with aging and underlying conditions. GO and KEGG identified impaired signaling pathway may be due to low abundance miRNA which might be one of the contributing factors for the increasing severity and mortality in aged individuals and with other underlying conditions. Further, in vitro and in vivo studies are needed to validate some of these targets and identify potential therapeutic targets.
More Related Videos
07:58Quantitative Imaging of Lineage-specific Toll-like Receptor-mediated Signaling in Monocytes and Dendritic Cells from Small Samples of Human Blood
Published on: April 16, 2012
06:03Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
MicroRNAs
MicroRNAs
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
The Effect of Aging on Tissues
Pneumonia II: Pathophysiology
